Cita APA

Carr, B., Dmowski, W. P., O’Brien, C., Jiang, P., Burke, J., Jimenez, R., . . . Chwalisz, K. (2014). Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density. SAGE Publications.

Chicago Style Citation

Carr, Bruce, W. Paul Dmowski, Chris O’Brien, Ping Jiang, Joshua Burke, Roland Jimenez, Elizabeth Garner, i Kristof Chwalisz. Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects On Bone Mineral Density. SAGE Publications, 2014.

Cita MLA

Carr, Bruce, et al. Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects On Bone Mineral Density. SAGE Publications, 2014.